EUVIMEDEUVIMED entdecken
Crossref

Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors

Shivee Gilja iD, Vikram Vasan iD, Arvind Kumar, Scott A Roof, Eric M Genden, Diana N Kirke

Head & Neck · 2024

DOI: 10.1002/hed.27736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Shivee Gilja und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Neck Dissection, Laryngeal Neoplasms, Neoplasm Staging. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 2018, the National Comprehensive Cancer Network treatment guidelines began recommending the use of neck dissection during surgical management of stage I‐II supraglottic laryngeal squamous cell carcinoma (LSCC).

Methods

Trends and factors associated with the use of neck dissection during larynx‐preserving surgery for patients with cT1‐2, N0, M0 supraglottic LSCC in the National Cancer Database (2004–2020) were evaluated using multivariable‐adjusted logistic regression.

Results

Of the 2080 patients who satisfied study eligibility criteria, 633 (30.4%) underwent neck dissection. Between 2018 and 2020, the rate of neck dissection was 39.0% (114/292). After multivariable adjustment, academic facility type, undergoing biopsy prior to surgery, and more radical surgery were significant predictors of receiving neck dissection.

Conclusions

The results of this national analysis suggest that the utilization of guideline‐concordant neck dissection for management of stage I‐II supraglottic LSCC remains low and highlight the need to promote the practice of neck dissection for this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neck DissectionLaryngeal NeoplasmsNeoplasm StagingHumansMaleFemaleMiddle AgedAgedCarcinoma, Squamous CellUnited StatesRetrospective StudiesDatabases, FactualLaryngectomy

Stichwörter der Autor:innen

elective neck dissectionguideline‐concordant treatmentlaryngeal squamous cell carcinomalarynx‐preserving surgerysupraglottic cancer

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Shivee Gilja, Vikram Vasan

Zitieren

APA

Gilja, S., Vasan, V., Kumar, A., Roof, S. A., Genden, E. M., & Kirke, D. N. (2024). Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors. Head & Neck. https://doi.org/10.1002/hed.27736

Vancouver

Gilja S, Vasan V, Kumar A, Roof SA, Genden EM, Kirke DN. Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors. Head & Neck. 2024. doi:10.1002/hed.27736

BibTeX
@article{Gilja2024,
  author = {Gilja, Shivee and Vasan, Vikram and Kumar, Arvind and Roof, Scott A and Genden, Eric M and Kirke, Diana N},
  title = {Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors},
  journal = {Head & Neck},
  year = {2024},
  doi = {10.1002/hed.27736}
}
Kostenlos starten →